{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:46:55Z","timestamp":1781887615840,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jval.2024.06.017","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T02:27:07Z","timestamp":1720232827000},"page":"1400-1407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mapping the Lequesne Functional Index Into the EQ-5D-5L Utility Index in Patients With Knee Osteoarthritis"],"prefix":"10.1016","volume":"27","author":[{"given":"Nadia","family":"Dardenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Fran\u00e7oise","family":"Donneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jval.2024.06.017_bib1","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.jval.2024.06.017_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.semarthrit.2013.07.003","article-title":"Health economics in the field of osteoarthritis: an expert\u2019s consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"43","author":"Hiligsmann","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jval.2024.06.017_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0272989X8900900209","article-title":"Quality-adjusted life years, utility theory, and healthy-years equivalents","volume":"9","author":"Mehrez","year":"1989","journal-title":"Med Decis Mak"},{"issue":"2","key":"10.1016\/j.jval.2024.06.017_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","article-title":"EQ-5D and the EuroQol Group: past, present and future","volume":"15","author":"Devlin","year":"2017","journal-title":"Appl Health Econ Health Policy"},{"issue":"6","key":"10.1016\/j.jval.2024.06.017_bib5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jval.2021.01.003","article-title":"Response mapping methods to estimate the EQ-5D-5L from the western Ontario McMaster universities osteoarthritis in patients with hip or knee osteoarthritis","volume":"24","author":"Ayala","year":"2021","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2024.06.017_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11136-012-0189-4","article-title":"Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score","volume":"22","author":"Dakin","year":"2013","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2024.06.017_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13018-023-03522-0","article-title":"Mapping of disease-specific Oxford Knee Score onto EQ-5D-5L utility index in knee osteoarthritis","volume":"18","author":"Fawaz","year":"2023","journal-title":"J\u00a0Orthop Surg Res"},{"issue":"1","key":"10.1016\/j.jval.2024.06.017_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12955-020-01435-8","article-title":"Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis","volume":"18","author":"Martin-Fernandez","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2024.06.017_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-12-37","article-title":"Modelling the relationship between the WOMAC osteoarthritis Index and EQ-5D","volume":"12","author":"Wailoo","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.jval.2024.06.017_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1524-4733.2010.00770.x","article-title":"Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index","volume":"13","author":"Xie","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2024.06.017_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009748709102182","article-title":"Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests","volume":"65","author":"Lequesne","year":"1987","journal-title":"Scand J Rheumatol Suppl"},{"issue":"11","key":"10.1016\/j.jval.2024.06.017_bib12","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s11136-018-1929-x","article-title":"Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness","volume":"27","author":"Bilbao","year":"2018","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.jval.2024.06.017_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2024.06.017_bib14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s40744-021-00363-3","article-title":"Knee osteoarthritis pain management with an innovative high and low molecular weight hyaluronic acid formulation (HA-HL): A randomized clinical trial","volume":"8","author":"Migliore","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"10","key":"10.1016\/j.jval.2024.06.017_bib15","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2024.06.017_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40258-021-00639-3","article-title":"The Danish EQ-5D-5L value set: A hybrid model using cTTO and DCE data","volume":"19","author":"Jensen","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"10.1016\/j.jval.2024.06.017_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40273-019-00876-4","article-title":"A\u00a0French value set for the EQ-5D-5L","volume":"38","author":"Andrade","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.jval.2024.06.017_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","article-title":"German value set for the EQ-5D-5L","volume":"36","author":"Ludwig","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jval.2024.06.017_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"K\u00a0MV Tariff for the Five-Level Version of EQ-5D","volume":"19","author":"MAAE","year":"2016","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2024.06.017_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2024.06.017_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jval.2019.09.2755","article-title":"Mapping WOMAC onto the EQ-5D-5L utility index in patients with hip or knee osteoarthritis","volume":"23","author":"Bilbao","year":"2020","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2024.06.017_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0962280210379079","article-title":"Statistical approaches to analyse patient-reported outcomes as response variables: an application to health-related quality of life","volume":"21","author":"Arostegui","year":"2012","journal-title":"Stat Methods Med Res"},{"issue":"8","key":"10.1016\/j.jval.2024.06.017_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1023\/A:1008938326604","article-title":"The use of the Tobit model for analyzing measures of health status","volume":"9","author":"Austin","year":"2000","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2024.06.017_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1524-4733.2002.54128.x","article-title":"A\u00a0comparison of methods for analyzing health-related quality-of-life measures","volume":"5","author":"Austin","year":"2002","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2024.06.017_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jval.2010.12.009","article-title":"Analysis of SF-6D index data: is beta regression appropriate?","volume":"14","author":"Hunger","year":"2011","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2024.06.017_bib26","first-page":"799","article-title":"Beta regression for modelling rates and proportions","volume":"31","author":"Silvia Ferrari","year":"2004","journal-title":"J\u00a0Appl Stat"},{"issue":"3","key":"10.1016\/j.jval.2024.06.017_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/096228029500400302","article-title":"Generalized additive models for medical research","volume":"4","author":"Hastie","year":"1995","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jval.2024.06.017_bib28","article-title":"Factors associated with clinical and radiographic severity in people with osteoarthritis: A cross-sectional population-based study","volume":"8","author":"Costa","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jval.2024.06.017_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14737167.2018.1517046","article-title":"Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients","volume":"19","author":"Ameri","year":"2019","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.jval.2024.06.017_bib30","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.21037\/qims-22-242","article-title":"Automatic prediction model for online diaphragm motion tracking based on optical surface monitoring by machine learning","volume":"13","author":"Dai","year":"2023","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"10.1016\/j.jval.2024.06.017_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients","volume":"1","author":"McGraw","year":"1996","journal-title":"Psychol Methods"},{"issue":"2","key":"10.1016\/j.jval.2024.06.017_bib32","first-page":"155","article-title":"A\u00a0guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J\u00a0Chiropr Med"},{"key":"10.1016\/j.jval.2024.06.017_bib33","series-title":"Vector Generalized Linear Addit Models","first-page":"1","author":"TW","year":"2023"},{"key":"10.1016\/j.jval.2024.06.017_bib34","unstructured":"YY. Machine Learning Evaluation Metrics;\u00a02022."},{"key":"10.1016\/j.jval.2024.06.017_bib35","series-title":"Various Coefficients of Interrater Reliability and Agreement","year":"2019"},{"issue":"1","key":"10.1016\/j.jval.2024.06.017_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12955-018-0857-3","article-title":"Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement","volume":"16","author":"Dakin","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.jval.2024.06.017_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A\u00a0review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2024.06.017_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1477-7525-11-151","article-title":"Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database","volume":"11","author":"Dakin","year":"2013","journal-title":"Health Qual Life Outcomes"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524027566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301524027566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:37:07Z","timestamp":1759351027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301524027566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1098301524027566"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2024.06.017","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the Lequesne Functional Index Into the EQ-5D-5L Utility Index in Patients With Knee Osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2024.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}